GENB insider transactions
Generate Biomedicines Inc. (GENB) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for GENB
- New insider Pioneering Medicines 02, Llc claimed ownership of 1,562,500 shares (SEC Form 3)3 - Generate Biomedicines, Inc. (0002100782) (Issuer)
- Chief Executive Officer Nally Michael bought $240,000 worth of shares (20,000 units at $12.00), increasing direct ownership by 4% to 572,707 units (SEC Form 4)4 - Generate Biomedicines, Inc. (0002100782) (Issuer)
- SEC Form 4 filed by Director Vessey Rupert4 - Generate Biomedicines, Inc. (0002100782) (Issuer)
- Chief People Officer Grous Beth bought $4,800 worth of shares (300 units at $16.00) (SEC Form 4)4 - Generate Biomedicines, Inc. (0002100782) (Issuer)
- SEC Form 4 filed by Director Arnold Frances4 - Generate Biomedicines, Inc. (0002100782) (Issuer)
- SEC Form 4 filed by Chief Legal Officer & GC Martin Sean4 - Generate Biomedicines, Inc. (0002100782) (Issuer)
- SEC Form 4 filed by Chief Medical Officer Lee Laurie Anne4 - Generate Biomedicines, Inc. (0002100782) (Issuer)
- SEC Form 4 filed by Director Simonian Nancy A4 - Generate Biomedicines, Inc. (0002100782) (Issuer)
- President & CFO Silvers Jason bought $32,000 worth of shares (2,000 units at $16.00) (SEC Form 4)4 - Generate Biomedicines, Inc. (0002100782) (Issuer)
- Director Afeyan Noubar converted options into 32,969,159 shares and bought $75,000,000 worth of shares (4,687,500 units at $16.00) (SEC Form 4)4 - Generate Biomedicines, Inc. (0002100782) (Issuer)
- SEC Form 4 filed by Chief Technology Officer Grigoryan Gevorg4 - Generate Biomedicines, Inc. (0002100782) (Issuer)
- Chief Executive Officer Nally Michael converted options into 658,327 shares (SEC Form 4)4 - Generate Biomedicines, Inc. (0002100782) (Issuer)
- Director Bancel Stephane converted options into 724,160 shares (SEC Form 4)4 - Generate Biomedicines, Inc. (0002100782) (Issuer)
- Director Mendillo Jane L bought $24,000 worth of shares (1,500 units at $16.00) (SEC Form 4)4 - Generate Biomedicines, Inc. (0002100782) (Issuer)
- SEC Form 4 filed by Director Fanucci Marsha4 - Generate Biomedicines, Inc. (0002100782) (Issuer)
- SEC Form 4 filed by Director Parker Paul Gray4 - Generate Biomedicines, Inc. (0002100782) (Issuer)
- Director Afeyan Noubar converted options into 32,969,159 shares and bought $75,000,000 worth of shares (4,687,500 units at $16.00) (SEC Form 4)4 - Generate Biomedicines, Inc. (0002100782) (Issuer)